Women's Health Study
To test the benefits and risks of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer. **General contact: email@example.com**
- Start Year
- End Year
- Trial (1991-2994): funded jointly by the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). Observational follow-up (2004 - ongoing): NCI
- Study design
- Clinical trial cohort
- Follow Up
- At the end of the trial (2004), participants were invited to be followed observationally, by completing yearly endpoint and risk factor questionnaires, to evaluate cancer and CVD hypotheses.
Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med. 2000 Jan-Feb;9(1):19-27. doi: 10.1089/152460900318911.
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
- Supplementary Information
- Health professionals. Women.
No coverage data about the variables classifications are available.